Veeva KOL Data subscription delivers consolidated, always up-to-date
view of key stakeholders directly within Veeva CRM
PLEASANTON, Calif.--(BUSINESS WIRE)--
Veeva Systems kicked off its European Commercial Summit today with the
announcement of Veeva
KOL Data, now available as a subscription. Eliminating information
silos, Veeva KOL Data can provide a single, global source of key
stakeholder information for better key opinion leader (KOL)
identification and engagement. By delivering a consolidated feed of
continuously updated information and unique insights on KOLs worldwide,
the solution maximizes coverage of core decision makers and enables a
tailored KOL experience.
In a world where a multitude of stakeholders and complex treatments are
increasingly the norm, the need for more effective KOL engagement has
never been more acute. Companies are challenged to improve the
efficiency of all customer-facing teams to meet the demands. “It’s no
longer about a few scientific experts – there are more people, more
channels, and more products,” said Robert Groebel, Veeva’s vice
president of global medical strategy. “Coupling the right information
about the right stakeholders with effective execution can make or break
a product in a region or category.”
A typical large life sciences company can have hundreds of disparate
stakeholder data silos, resulting in wasted time and money as well as
increased risk through incomplete KOL coverage.
Veeva KOL Data overcomes this problem by offering a single, global
database that brings together a unique combination of critical data,
marrying traditional KOL data sources with other sources such as survey
research, expert interviews, claims data, and social media insights.
Empowered with comprehensive data, companies can efficiently reach all
relevant thought leaders globally.
With seamless CRM integration, in-depth Veeva KOL Data profiles are
delivered directly to medical science liaisons (MSLs), streamlining
meeting preparation and enabling personalized KOL engagement. Real-time
KOL activity alerts can prompt immediate action, so medical teams are
always current and can respond quickly to critical events.
“Most organizations have multiple, outdated profiles for only a portion
of the KOLs they should cover,” said Killian Weiss, general manager of
KOL solutions at Veeva. “And because the data is stale and difficult to
access, MSLs spend at least an hour per week attempting to piece
together their own picture of KOLs. The result is thousands of hours of
lost MSL productivity each year. Veeva KOL Data eliminates wasted hours
and frees teams to focus their efforts on engaging with all the right
stakeholders.”
Available today as subscription service, Veeva KOL Data provides rich
stakeholder information, across therapeutic categories and regions.
Equipped with a complete source of robust data for the enterprise,
companies can improve planning and alignment while minimizing the need
for parallel systems and complicated integrations.
In other news today, Veeva introduced Veeva
Medical CRM to enable better KOL engagements. Additionally,
Veeva announced the availability of Veeva
CRM Suggestions, which leverages the power of data science to
correlate large quantities of data with actual customer behaviors to
recommend next best actions to take across which channels.
Additional Information
For additional details on Veeva KOL
Data, visit: veeva.com/kol-data
Stay
updated on the latest Veeva news on LinkedIn: linkedin.com/company/veeva-systems
Follow
@veevasystems on Twitter: twitter.com/veevasystems
Like
Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 375 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in Europe,
Asia, and Latin America. For more information, visit www.veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” in the company’s filing on Form
10-Q for the period ended July 31, 2015. This is available on the
company’s website at http://www.veeva.com
under the Investors section and on the SEC’s website at www.sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
1. MSL Insights, A Global Survey Reveals: The Medical Science
Liaison competencies that contribute most to success, Medical Science
Liaison Society, July 2015.
® 2015 Veeva Systems Inc. All rights reserved. Veeva and the Veeva logo
are trademarks of Veeva Systems Inc. Veeva Systems Inc. owns other
registered and unregistered trademarks.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151203005470/en/
Source: Veeva Systems Inc.